Stockreport

Why IDEAYA Biosciences (IDYA) Is Up 7.5% After Early Data From First-in-Class Cancer Combo [Yahoo! Finance]

IDEAYA Biosciences, Inc.  (IDYA) 
Last ideaya biosciences, inc. earnings: 3/24 06:00 am Check Earnings Report
PDF inhibitor, in DLL3-upregulated solid tumors such as small cell lung cancer, neuroendocrine tumors, and melanoma. The update also highlighted early signs of clinical ac [Read more]